» Articles » PMID: 27041382

Predictors of Remission, Erosive Disease and Radiographic Progression in a Colombian Cohort of Early Onset Rheumatoid Arthritis: a 3-year Follow-up Study

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2016 Apr 5
PMID 27041382
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of the study is to find predictors of remission, radiographic progression (RP), and erosive disease in a cohort of patients with early onset rheumatoid arthritis (EORA) that followed a therapeutic protocol aiming at remission, in a real world tight-control setting. EORA patients were enrolled in a 3-year follow-up study. Clinical, biological, immunogenetic, and radiographical data were analyzed. Radiographs were scored according to Sharp-van der Heijde (SvdH) method. RP was defined by an increase of 3 units in 36 months. Remission was defined as DAS28 <2.6. A stepwise multiple logistic regression model was used to identify independent predictors of the three target outcomes. One hundred twenty-nine patients were included. Baseline disease activity was high. Significant overall improvement was observed, but only 33.3 % achieved remission. At 36 month, 50.4 % (65) of patients showed erosions. RP was observed in 62.7 % (81) of cases. Statistical analysis showed that baseline SvdH score was the only predictive factor associated with the three outcomes evaluated. Lower HAQ-DI and absence of autoantibodies were predictive of remission. Higher levels of ESR and presence of erosions at entry were predictive of RP. Independent baseline predictors of incident erosive disease were anti-CCP and RF positivity, symptom duration at baseline >3 months, and presence of HLA-DRB1 shared epitope. Radiographic damage at baseline was the main predictor of outcomes. Autoantibodies, HAQ and ESR at baseline, symptom duration before diagnosis, and HLA-DRB1 status had influence on clinical course and development of structural joint damage in Colombian RA patients.

Citing Articles

Biomarkers in the diagnosis, prognosis and management of rheumatoid arthritis: A comprehensive review.

Sahin D, Di Matteo A, Emery P Ann Clin Biochem. 2024; 62(1):3-21.

PMID: 39242085 PMC: 11707974. DOI: 10.1177/00045632241285843.


Anxiety, Distress, and Depression in Elderly Rheumatoid Arthritis Patients.

Karokis D, Karamanis D, Xesfingi S, Antonopoulos I, Politi E, Bounas A Mediterr J Rheumatol. 2023; 33(4):394-406.

PMID: 37034365 PMC: 10075367. DOI: 10.31138/mjr.33.4.394.


Increased remission with fewer corticosteroids and more biologics in rheumatoid arthritis at 7-year follow-up in real-life conditions.

Larid G, Vix J, Garlantezec R, Loppin E, Gervais E Sci Rep. 2022; 12(1):2563.

PMID: 35169251 PMC: 8847581. DOI: 10.1038/s41598-022-06584-y.


Serum Reactive Oxygen Metabolites as a Predictor of Clinical Disease Activity Index, Simplified Disease Activity Index, and Boolean Remissions in Rheumatoid Arthritis Patients Treated With Biologic Agents.

Nakajima A, Terayama K, Sonobe M, Akatsu Y, Saito J, Norimoto M Cureus. 2021; 13(11):e19759.

PMID: 34938634 PMC: 8685306. DOI: 10.7759/cureus.19759.


Effective factors on Sharp Score in patients with rheumatoid arthritis: a retrospective study.

Wen J, Liu J, Xin L, Wan L, Jiang H, Sun Y BMC Musculoskelet Disord. 2021; 22(1):865.

PMID: 34627206 PMC: 8502366. DOI: 10.1186/s12891-021-04742-3.


References
1.
Kroot E, de Jong B, van Leeuwen M, Swinkels H, van den Hoogen F, Vant Hof M . The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000; 43(8):1831-5. DOI: 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6. View

2.
Karlson E, Chibnik L, Cui J, Plenge R, Glass R, Maher N . Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study. Ann Rheum Dis. 2007; 67(3):358-63. PMC: 2945890. DOI: 10.1136/ard.2007.071662. View

3.
van Zeben D, Hazes J, Zwinderman A, Cats A, Schreuder G, DAmaro J . Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. Arthritis Rheum. 1991; 34(7):822-30. DOI: 10.1002/art.1780340707. View

4.
Brennan P, Harrison B, Barrett E, Chakravarty K, Scott D, Silman A . A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ. 1996; 313(7055):471-6. PMC: 2351858. DOI: 10.1136/bmj.313.7055.471. View

5.
Aranda F, Peres Wingeyer S, Schneeberger E, Valerio M, Martin E, Dal Pra F . The -308 G/A polymorphism in the tumor necrosis factor-α gene is not associated with development and progression of rheumatoid arthritis in Argentinean patients. Int J Rheum Dis. 2014; 19(5):476-81. DOI: 10.1111/1756-185X.12343. View